prostate cancer
Conditions
Interventions
experimental group:Urinary catheter removal 5 days after laparoscopic radical prostatectomy
control group:Urinary catheter removal 14 days after laparoscopic radical prostatectomy
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Male
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age: 50-75 years old 2. T1-3NxM0 prostate cancer patients who undergo laparoscopic radical prostatectomy, T1-3NxM0 prostate cancer patients have received neoadjuvant endocrine therapy for no more than 3 months before surgery can be included; 3. Be able to cooperate and complete follow-up and related examinations; 4. Agree to participate in this experiment and sign an informed consent form
Exclusion criteria
Exclusion criteria: 1. Preoperative complications such as urethral stricture, neurogenic bladder, cognitive impairment, and other malignant tumors were not cured; 2. Previous medical history of receiving prostate cancer treatment, including surgery, long-term endocrine therapy (over 3 months), chemotherapy, radiotherapy, targeted therapy, and immunotherapy; 3. Have a history of pelvic and lower abdominal surgeries; Patients with a history of prostate resection/enucleation surgery; 4. Concurrent with serious other systemic diseases, according to the judgment of the researcher, may interfere with the treatment, evaluation, or compliance of the trial; 5. Contraindications to radical prostatectomy for prostate cancer 6. Participate in any other ongoing experiments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete urinary continence rate at 3 months after surgery;Complete urinary continence rate at 12 months after surgery;Incidence rate of urinary fistula within 3 months after operation;Incidence rate of urinary retention within 3 months after operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| The complete urinary continence rate on the day of catheter removal and 1 month, 6 months, and 24 months after surgery;the total incidence of complications at each follow-up time point after surgery; | — |
Countries
China
Contacts
Public ContactJun Pan
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed